MedTrace Logo

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

NCT06578962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2024-08-30

No results posted yet for this study

Summary

The aim of the study is to evaluate, with clinical, biological and biometrological assessment methods, the effectiveness of RV3438G shampoo, after 2 weeks of short intensive treatment phase and also the effects of a maintenance phase of 8 weeks in association with a neutral shampoo, or with a gentle balancing shampoo, compared to a neutral shampoo used single.

This is a bicentric, comparative (during the maintenance phase), randomized, controlled and open study, in parallel groups conducted in subjects having mild to moderate recurrent squamous states, for 10 weeks.

4 visits are planned. The maximum duration of the study is 74 days from inclusion visit to the End-of-study visit.

The study area is the whole scalp.

Conditions

  • Dermatitis, Seborrheic

Interventions

OTHER

Phase 1: short intensive treatment phase

During the treatment phase (phase 1), all subjects of the study applied the tested product RV3438G, thrice a week, for 2 weeks.

OTHER

Phase 2 : Tested product RV3438G associated with gentle balancing shampoo

During maintenance phase (phase 2): the tested product RV3438G was applied once a week for 8 weeks the gentle balancing shampoo RD1089O was applied twice a week alternately with the RV3438G shampoo, for 8 weeks.

OTHER

Phase 2 : Tested product RV3438G associated with neutral shampoo

During maintenance phase (phase 2): the tested product RV3438G was applied once a week for 8 weeks the neutral shampoo RD0057H was applied twice a week alternately with the RV3438G shampoo, for 8 weeks.

OTHER

Phase 2 : neutral shampoo

During maintenance phase (phase 2): the neutral shampoo RD0057H was applied thrice a week for 8 weeks.

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    lead INDUSTRY

Principal Investigators

  • Pascal REYGAGNE, Dr · Centre de santé SABOURAUD - Hôpital Saint Louis

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-09
Primary Completion
2021-05-11
Completion
2021-05-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06578962 on ClinicalTrials.gov